PharmaOnco™ WEHI 164 Cancer Cell Line (CAT#: ITS-0523-LX93)

Datasheet

Datasheet

Overview
Specification

Applications

in vitro and in vivo assay

Organism

Mouse

Tissue

Fibrosarcoma

Disease

Fibrosarcoma

Morphology

Fibroblast-like

Biosafety Level

BSL-2

Tumorigenicity

Tumorigenic

Split Ratio

A ratio of 1:5 to 1:20 is recommended

Medium Renewal

2 times per week

Related Products

PharmaOnco™ Human MM.1S-Luc Reporter Cell Line (CAT#: IOC-ZP284)
PharmaOnco™ Jurkat-Tg(Human HVEM)-NF-κB Reporter Cell Line, Single Clone (CAT#: ITS-0822-HMM169)
PharmaOnco™ RH7777-Tg(Human LPA2 Receptor) Division-Arrested Cell, Single Clone (CAT#: ITS-0624-HMM603)
PharmaOnco™ Human SK-N-AS Cancer Cell Line (CAT#: IOC-ZP292)
PharmaOnco™ HEK293T-Tg(Human MC4 Receptor) Stable Cell Line, Single Clone (CAT#: ITS-0624-HMM272)
PharmaOnco™ Panc 02.13 Cancer Cell Line (CAT#: ITS-0523-LX88)
PharmaOnco™ SK-MES-1 Cancer Cell Line (CAT#: ITS-0523-LX53)
PharmaOnco™ CHO-Tg(Human Claudin 18.2) Stable Cell Line, Single Clone (CAT#: ITS-0822-HMM134)

For Research Use Only | Not For Clinical Use

Online Inquiry

Copyright © 2026 Creative Biolabs. All Rights Reserved.

ISO 9001 Certified - Creative Biolabs Quality Management System.

Close

Thanksgiving

Thanksgiving